These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28730788)

  • 1. Topoisomerase I deregulation in laryngeal squamous cell carcinomas based on tissue microarray analysis.
    Papadas TA; Tsiambas E; Mastronikolis NS; Karameris A; Mastronikolis SN; Papadas AT; Fotiades PP; Ragos V
    J BUON; 2017; 22(3):771-776. PubMed ID: 28730788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase IIa protein expression analysis in oral squamous cell carcinoma.
    Papanikolaou V; Kyrodimos E; Mastronikolis N; Tsiambas E; Ragos V; Chrysovergis A
    J BUON; 2021; 26(3):769-773. PubMed ID: 34268934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of PTEN Expression in Laryngeal Squamous Cell Carcinoma Based on Tissue Microarray Digital Analysis.
    Mastronikolis NS; Tsiambas E; Papadas TA; Karameris A; Ragos V; Peschos D; Mastronikolis SN; Papadas AT; Liatsos C; Armata IE; Fotiades PP
    Anticancer Res; 2017 Oct; 37(10):5521-5524. PubMed ID: 28982865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
    Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
    J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Topoisomerases Complex Deregulation on Head and Neck Carcinoma Genomic Instability.
    Kyrodimos E; Chrysovergis A; Mastronikolis N; Tsiambas E; Ragos V; Peschos D; Spyropouloy D; Pantos P; Niotis A; Papanikolaou V
    Anticancer Res; 2021 Jun; 41(6):2773-2779. PubMed ID: 34083267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase IIalpha (TopoIIa) A New Promising Marker for Early Detection of Laryngeal Squamous Cell Carcinoma: An Immunohistochemical Study.
    Salama MEM; Yaqout MAT; Habib FM; Abdel-Salam SM
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):2135-2139. PubMed ID: 37378945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples.
    Durand-Faucher K; Rabinovitch-Chable H; Dzugan H; Charret S; Aubry K; Genet D; Léobon S; Tubiana-Mathieu N; Cook-Moreau J; Rigaud M; Sturtz FG
    Clin Chem Lab Med; 2005; 43(7):707-14. PubMed ID: 16207129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of topoisomerase IIa expression in pancreatic ductal adenocarcinoma: a pilot study using chromogenic in situ hybridization and immunohistochemistry on tissue microarrays.
    Tsiambas E; Karameris A; Tiniakos DG; Karakitsos P
    Pancreatology; 2007; 7(1):45-52. PubMed ID: 17449965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of matrix metalloproteinase 9 (MMP-9) protein expression in laryngeal squamous cell carcinomas based on digital image analysis.
    Papadas TA; Naxakis SS; Mastronikolis NS; Stathas T; Karabekos NCh; Tsiambas E
    J BUON; 2013; 18(4):977-81. PubMed ID: 24344026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human deoxyribonucleic acid topoisomerases: molecular targets of anticancer drugs.
    Holden JA
    Ann Clin Lab Sci; 1997; 27(6):402-12. PubMed ID: 9433537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of DNA topoisomerase II-α: Clinical significance in laryngeal carcinoma.
    Feng Y; Zhang H; Gao W; Wen S; Huangfu H; Sun R; Bai W; Wang B
    Oncol Lett; 2014 Oct; 8(4):1575-1580. PubMed ID: 25202370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
    Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
    Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
    Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
    Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of epidermal growth factor receptor gene and chromosome 7 alterations in squamous cell carcinoma of the larynx, using chromogenic in situ hybridization on tissue microarrays.
    Tsiambas E; Stavrakis I; Lazaris AC; Karameris A; Patsouris E
    J Laryngol Otol; 2007 Jun; 121(6):563-70. PubMed ID: 16882359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of camptothecin analogues as antitumor agents.
    Slichenmyer WJ; Rowinsky EK; Donehower RC; Kaufmann SH
    J Natl Cancer Inst; 1993 Feb; 85(4):271-91. PubMed ID: 8381186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of topoisomerase II alpha immunostaining in urothelial bladder carcinoma.
    Nakopoulou L; Zervas A; Lazaris AC; Constantinides C; Stravodimos C; Davaris P; Dimopoulos C
    J Clin Pathol; 2001 Apr; 54(4):309-13. PubMed ID: 11304849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase IIa Protein Expression Patterns in Laryngeal Squamous Cell Carcinoma.
    Papanikolaou V; Chrysovergis A; Mastronikolis N; Tsiambas E; Ragos V; Peschos D; Stavraka C; Roukas D; Kyrodimos E
    Anticancer Res; 2020 Feb; 40(2):807-811. PubMed ID: 32014923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.
    Coleman LW; Bronstein IB; Holden JA
    Anticancer Res; 2001; 21(2A):1167-72. PubMed ID: 11396158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting topoisomerase IIa in endometrial adenocarcinoma: a combined chromogenic in situ hybridization and immunohistochemistry study based on tissue microarrays.
    Tsiambas E; Alexopoulou D; Lambropoulou S; Gerontopoulos K; Karakitsos P; Karameris A
    Int J Gynecol Cancer; 2006; 16(3):1424-31. PubMed ID: 16803541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No alteration in DNA topoisomerase I gene related to CPT-11 resistance in human lung cancer.
    Ohashi N; Fujiwara Y; Yamaoka N; Katoh O; Satow Y; Yamakido M
    Jpn J Cancer Res; 1996 Dec; 87(12):1280-7. PubMed ID: 9045964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.